The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)

NCT01106625 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

469

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Canagliflozin
DRUG: Placebo
DRUG: Metformin
DRUG: Sulphonylruea

Sponsor

Janssen Research & Development, LLC